Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Multiple Sclerosis”

1,018 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,018 results

Not applicableStudy completedNCT03302442
What this trial is testing

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT06987851
What this trial is testing

An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD

Who this might be right for
Multiple Sclerosis
Biocad 44
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Post-approval studies (Phase 4)Ended earlyNCT02665221
What this trial is testing

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Who this might be right for
Multiple Sclerosis
NYU Langone Health 30
Testing effectiveness (Phase 2)Study completedNCT05131828
What this trial is testing

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 70
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Early research (Phase 1)Not Yet RecruitingNCT07749157
What this trial is testing

Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 85
Post-approval studies (Phase 4)Study completedNCT01333501
What this trial is testing

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT03752307
What this trial is testing

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

Who this might be right for
Multiple Sclerosis
University of New Mexico 2
Testing effectiveness (Phase 2)Study completedNCT02410200
What this trial is testing

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 22
Not applicableNot Yet RecruitingNCT07645937
What this trial is testing

Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Hanifi Bal 30
Large-scale testing (Phase 3)Study completedNCT02746744
What this trial is testing

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Anders Svenningsson 200
Testing effectiveness (Phase 2)Study completedNCT00203112
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 44
Not applicableStudy completedNCT02686684
What this trial is testing

Tecfidera Diffusion Tensor Imaging

Who this might be right for
Multiple Sclerosis, Dimethyl Fumarate, Diffusion Tensor Imaging Magnetic Resonance Imaging
University at Buffalo 115
Not applicableActive Not RecruitingNCT07757568
What this trial is testing

Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
University of Colorado, Denver 11
Early research (Phase 1)Study completedNCT01808885
What this trial is testing

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Hoffmann-La Roche 44
Not applicableStudy completedNCT03758820
What this trial is testing

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueCognitive Therapy
Réseau Sep Idf Ouest 105
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Next Page